Joel W. McCleary

PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Sawyer Miller Group International is a public relations firm.

Four Seasons Ventures LLC (Four Seasons Ventures) is a venture capital firm founded in 2000 by Joel McCleary and Véronique Bardach. The firm is headquartered in Washington, District of Columbia.

Raydiance, Inc. manufactured software-controlled ultrashort pulse (USP) lase. The company was founded by Jeff Bullington, Peter J. Delfyett, Scott H. Davison, Joel W. McCleary and Barry Martin Schuler in 2003 and was headquartered in Petaluma, CA.

Part of Madrigal Pharmaceuticals, Inc., Kava Pharmaceuticals, Inc. develops pharmaceutical products. The American company was founded by Joel W. McCleary. Kava Pharmaceuticals was acquired by Synta Pharmaceuticals Corp. on January 01, 2004 for $1.11 million.

Democratic Party of New Mexico operates as a political party. The company is headquartered in Albuquerque, NM.

PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD.